AMN Healthcare (AMN) Q3 2026 Earnings Call Transcript
AMN Healthcare reported Q3 2026 revenue of $717M, up 13% YoY. Nurse and Allied revenue grew 16% YoY to $460M, driven by demand and operational improvements. Q4 revenue is projected to decline 13-15% YoY. Gross margin was 31.9%, and net income was $33M. The company expects long-term growth from workforce solutions and technology enhancements.
How this was made

The 30-second read
Why it matters
The earnings release highlights robust Q3 growth but signals a slowdown in Q4, especially in travel nurse revenue due to visa bottlenecks.
Market read
First-report earnings with material numbers and guidance shift, offering immediate trading considerations.
What to watch
International visa delays and labor disruption revenue volatility may be temporary and not fully reflected in the stock price.
Background
AMN Healthcare provides staffing solutions to health systems, with segments including Nurse & Allied, Locum Tenens, and Technology services.
Ticker impact
Q3 2026 earnings released with $717M revenue, 13% YoY growth and guidance indicating Q4 revenue down 13-15% YoY.
likely modest pressure as investors price in lower Q4 guidance
Strong Q3 results are offset by guidance for a revenue decline in the next quarter, creating mixed sentiment.
Market effects
Healthcare staffing sector may see heightened scrutiny on future demand and labor disruption impacts.
U.S. healthcare staffing stocks could experience short-term volatility.
Limited to U.S. and international staffing firms with similar exposure.
Counterpoint
Despite Q4 revenue decline guidance, the strong Q3 performance and AI recruiting improvements could support a longer-term upside.
Key entities
- CompanyAMN Healthcare
U.S.-listed healthcare staffing firm (ticker AMN).


